Skip to main content
Journal cover image

Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.

Publication ,  Journal Article
Liu, R; Mitchell, DA
Published in: Cancer immunology, immunotherapy : CII
February 2010

Published In

Cancer immunology, immunotherapy : CII

DOI

EISSN

1432-0851

ISSN

0340-7004

Publication Date

February 2010

Volume

59

Issue

2

Start / End Page

183 / 193

Related Subject Headings

  • Survivin
  • Neovascularization, Pathologic
  • Neoplasm Proteins
  • Microtubule-Associated Proteins
  • Mice
  • Inhibitor of Apoptosis Proteins
  • Immunotherapy
  • Immunology
  • Humans
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, R., & Mitchell, D. A. (2010). Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors. Cancer Immunology, Immunotherapy : CII, 59(2), 183–193. https://doi.org/10.1007/s00262-009-0757-9
Liu, Rebecca, and Duane A. Mitchell. “Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.Cancer Immunology, Immunotherapy : CII 59, no. 2 (February 2010): 183–93. https://doi.org/10.1007/s00262-009-0757-9.
Liu R, Mitchell DA. Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors. Cancer immunology, immunotherapy : CII. 2010 Feb;59(2):183–93.
Liu, Rebecca, and Duane A. Mitchell. “Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.Cancer Immunology, Immunotherapy : CII, vol. 59, no. 2, Feb. 2010, pp. 183–93. Epmc, doi:10.1007/s00262-009-0757-9.
Liu R, Mitchell DA. Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors. Cancer immunology, immunotherapy : CII. 2010 Feb;59(2):183–193.
Journal cover image

Published In

Cancer immunology, immunotherapy : CII

DOI

EISSN

1432-0851

ISSN

0340-7004

Publication Date

February 2010

Volume

59

Issue

2

Start / End Page

183 / 193

Related Subject Headings

  • Survivin
  • Neovascularization, Pathologic
  • Neoplasm Proteins
  • Microtubule-Associated Proteins
  • Mice
  • Inhibitor of Apoptosis Proteins
  • Immunotherapy
  • Immunology
  • Humans
  • Clinical Trials as Topic